Heart Test Laboratories, Inc. Common Stock
HSCS
HSCS: Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
moreShow HSCS Financials
Recent trades of HSCS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HSCS's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Quantitative heart testing Sep. 20, 2022
-
Patent Title: Electrocardiogram-based assessment of diastolic function Sep. 20, 2022
-
Patent Title: Electrode and cable connections in electrocardiography systems May. 17, 2022
-
Patent Title: Time-frequency analysis of electrocardiograms Dec. 08, 2020
-
Patent Title: Quantitative heart testing Feb. 18, 2020
-
Patent Title: Electrode and cable connections in electrocardiography systems Jan. 01, 2019
-
Patent Title: Display screen or portion thereof with a graphical user interface Dec. 19, 2017
-
Patent Title: Quantitative heart testing Jul. 11, 2017
Federal grants, loans, and purchases
Followers on HSCS's company Twitter account
Number of mentions of HSCS in WallStreetBets Daily Discussion
Recent insights relating to HSCS
Recent picks made for HSCS stock on CNBC
ETFs with the largest estimated holdings in HSCS
Flights by private jets registered to HSCS